Please join Dr Jessica Randall-Carrick, ICS Co-Clinical Lead for Cardiovascular Disease (CVD) Prevention, to highlight opportunities and QoF ideas for improving the care of your patients with clinical risk factors (including Hypertension, Hyperlipidaemia / raised QRISK, Chronic Kidney Disease) and share the ‘headlines’ of the all new NICE guidelines & local newly developed C&P pathways… What do these mean for General Practice?

A perfect opportunity for some CPD & reflection over your mid-morning cuppa, or join us (virtually) for a brunch break; or later over your lunch break!

Agenda

Time Item
12:30 – 12:35 Welcome and introductions
12:35 – 14:10 Hypertension
• CVD Prevent & Eclipse data – opportunities & QoF • New Hypertension C&P formulary • Hypertension Pathfinder Programme – Community Pharmacy • NICE NG133 - Hypertension in pregnancy – Dx & Mx – April 2023
Hyperlipidaemia +/- Raised QRISK
• CVD Prevent & Eclipse data – opportunities & QoF • New NICE guidelines – what does this mean for General Practice? (May 2023) • InHip Programme – roll out – a new prototype for all willing practices? • Familial Hyperlipidaemia - new C&P pathway for systematic identification
Chronic Kidney Disease (CKD)
• CPD – setting the clinical context – why is this important? • CVD Prevent data – opportunities for improved care • NICE guidelines – what does this mean for General Practice?
Palpitations +/- Atrial Fibrillation
• New Community Palpitations Pathways – live 1st November • NICE MYG64 – KardiaMobile for detecting Atrial Fibrillation (July 2023)
14:10 - 14:20 Pre-Diabetes & Diabetes:
• 3TT and 8CP targets – simple ideas to achieve these easily • Healthy Living – new SMS campaign - for willing practices • Pathway to Remission (OVIVA) • Thrive Tribe – new NDPP provider introduction
14:20-14:30 Close
Date of next webinars/meetings: • Diabetes & Obesity Clinical Community meeting: 7th November 14:00 – 16:00hrs • CVD Meeting 2: 1st February 13.00– 15.00hrs